Myeloid Leukemia
What's New
Last Posted: Jun 13, 2024
- Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Lauren G Banaszak et al. JCO Precis Oncol 2024 8e2300518 - Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia
- Genomic Characterization of Partial Tandem Duplication Involving the KMT2A Gene in Adult Acute Myeloid Leukemia.
Andrew Seto et al. Cancers (Basel) 2024 16(9) - Advancing hospital-based health technology assessment: evaluating genomic panel contracting strategies for blood tumors through a multimethodology.
Susana Afonso et al. Int J Technol Assess Health Care 2023 39(1) e76 - The Clinical Utility of FLT3 Mutation Testing in Acute Leukemia: A Canadian Consensus.
Julie Bergeron et al. Curr Oncol 2023 30(12) 10410-10436 - Older Patients With AML Less Likely to Receive Genomic Testing, Study Finds
P Steinzor, AJMC, August 29, 2023 - Management of Down Syndrome-Associated Leukemias: A Review.
Anupam Verma et al. JAMA Oncol 2023 - Telomere Length and Clonal Hematopoiesis.
George Vassiliou et al. N Engl J Med 2023 5 (26) 2481-2484 - Molecular Heterogeneity of Pediatric AML with Atypical Promyelocytes Accumulation in Children-A Single Center Experience.
Aleksandra Borkovskaia et al. Genes 2023 14(3) - A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms.
Qiujin Shen et al. Cancer research communications 2023 2(4) 258-276
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: